Literature DB >> 1766036

Influence of the measurement location on the resistance index in the umbilical arteries: a hemodynamic approach.

P Vieyres1, A Durand, F Patat, P Descamps, J M Gregoire, D Pourcelot, L Pourcelot.   

Abstract

A computer model was used to study the primary factors generating the reduction in resistance index, (S-D)/S, values observed by ultrasonic Doppler measurements in the umbilical artery, from the fetal insertion to the placental insertion (S represents the amplitude of the systolic peak and D the amplitude of the diastolic peak). This hemodynamic approach shows that the placental resistance is the primary factor, the viscosity and the cord length playing secondary roles. Clinically, the position of the measurement along the cord is an important factor. To increase the sensitivity of the index, the Doppler measurement must be performed near the fetal insertion, whereas a measurement near the placental insertion will make the Doppler examination more specific.

Mesh:

Year:  1991        PMID: 1766036     DOI: 10.7863/jum.1991.10.12.671

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  3 in total

1.  Fetal heart modelling based on a pressure-volume relationship.

Authors:  E Ménigault; P Vieyres; B Lepoivre; A Durand; L Pourcelot; M Berson
Journal:  Med Biol Eng Comput       Date:  1997-11       Impact factor: 2.602

2.  Quantification of Wave Reflection in the Human Umbilical Artery From Asynchronous Doppler Ultrasound Measurements.

Authors:  Greg Stortz; Lindsay S Cahill; Anjana Ravi Chandran; Ahmet Baschat; John G Sled; Christopher K Macgowan
Journal:  IEEE Trans Med Imaging       Date:  2020-10-28       Impact factor: 10.048

3.  Hemodynamic impact of absent or reverse end-diastolic flow in the two umbilical arteries in growth-restricted fetuses.

Authors:  Edouard Lecarpentier; Anne Gaëlle Cordier; Francine Proulx; Jean Claude Fouron; Laurence Gitz; Gilles Grange; Alexandra Benachi; Vassilis Tsatsaris
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.